2,361 followers
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recur https://t.co/yy7R2iGIjQ #hvhebron #onco
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recur https://t.co/yy7R2iGIjQ #hvhebron #onco